St. James’s Place (STJ) Given top pick Rating at Numis Securities

Numis Securities restated their top pick rating on shares of St. James’s Place (LON:STJ) in a report published on Thursday morning.

Several other brokerages also recently weighed in on STJ. Shore Capital reissued a buy rating on shares of St. James’s Place in a report on Thursday, January 25th. JPMorgan Chase raised their price target on St. James’s Place from GBX 1,288 ($18.08) to GBX 1,313 ($18.43) and gave the stock an overweight rating in a report on Friday, January 12th. Deutsche Bank raised their price target on St. James’s Place from GBX 1,260 ($17.69) to GBX 1,310 ($18.39) and gave the stock a hold rating in a report on Thursday, January 4th. Credit Suisse Group raised their price objective on St. James’s Place from GBX 1,370 ($19.23) to GBX 1,390 ($19.51) and gave the stock an outperform rating in a research note on Friday, January 26th. Finally, Barclays restated an overweight rating and issued a GBX 1,361 ($19.10) price objective on shares of St. James’s Place in a research note on Friday, January 26th. Four equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus price target of GBX 1,327.85 ($18.64).

How to Become a New Pot Stock Millionaire

LON STJ traded down GBX 7.50 ($0.11) during trading on Thursday, hitting GBX 1,052 ($14.77). The company’s stock had a trading volume of 1,092,802 shares, compared to its average volume of 1,790,000. St. James’s Place has a fifty-two week low of GBX 1,008 ($14.15) and a fifty-two week high of GBX 1,279.50 ($17.96).

The company also recently disclosed a dividend, which will be paid on Friday, June 1st. Stockholders of record on Thursday, April 5th will be paid a GBX 27.45 ($0.39) dividend. This represents a dividend yield of 2.43%. This is a boost from St. James’s Place’s previous dividend of $15.41. The ex-dividend date is Thursday, April 5th.

In other news, insider Iain Cornish acquired 6,500 shares of St. James’s Place stock in a transaction dated Tuesday, March 20th. The stock was purchased at an average cost of GBX 1,136 ($15.95) per share, for a total transaction of £73,840 ($103,649.64).

TRADEMARK VIOLATION WARNING: “St. James’s Place (STJ) Given top pick Rating at Numis Securities” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another website, it was illegally copied and reposted in violation of US & international copyright and trademark law. The original version of this article can be accessed at https://www.tickerreport.com/banking-finance/3335975/st-jamess-place-stj-given-top-pick-rating-at-numis-securities.html.

About St. James’s Place

St. James's Place plc is a publicly owned investment manager. The firm launches and manages equity, fixed income, and balanced mutual funds for its clients. It invests in public equity and fixed income market across the globe. The firm was formerly known as St. James's Place Capital plc. St.

Analyst Recommendations for St. James`s Place (LON:STJ)

Receive News & Ratings for St. James's Place Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St. James's Place and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Esperion Therapeutics  PT Raised to $121.00 at Northland Securities
Esperion Therapeutics PT Raised to $121.00 at Northland Securities
Darrel S. Purdy Sells 3,500 Shares of Paramount Resources  Stock
Darrel S. Purdy Sells 3,500 Shares of Paramount Resources Stock
Antibe Therapeutics Inc  Director Sells C$74,750.40 in Stock
Antibe Therapeutics Inc Director Sells C$74,750.40 in Stock
Unit  Earning Somewhat Positive Press Coverage, Study Shows
Unit Earning Somewhat Positive Press Coverage, Study Shows
Oleg M. Pohotsky Buys 10,000 Shares of New America High Income Fund Inc.  Stock
Oleg M. Pohotsky Buys 10,000 Shares of New America High Income Fund Inc. Stock
Revance Therapeutics  Given News Impact Score of 0.22
Revance Therapeutics Given News Impact Score of 0.22


© 2006-2018 Ticker Report. Google+.